Zhao YM

No ORCID on file · 5 papers in corpus · active 2014-2020
2020
Chinese medical journal ·doi:10.1097/cm9.0000000000000785

BackgroundHuman epididymis secretory protein 4 (HE4) is a new ovarian cancer biomarker. The factors influencing HE4 levels are not clear, and the reference data in China are limited. Here, we aim to evaluate the effects of menopause and age…

2020
Journal of Cancer ·doi:10.7150/jca.38088

The adipokine resistin is linked with obesity, inflammation and various cancers, including breast cancer. This study sought to determine whether certain polymorphisms in the gene encoding resistin, RETN, increase the risk of breast cancer s…

2019
Medicine ·doi:10.1097/md.0000000000017854

Breast cancer is the most common diagnosed malignancy in women. This study genotyped blood samples from 236 Han Chinese women with breast cancer and 128 healthy controls for single nucleotide polymorphisms (SNPs) rs2977537, rs2929970, rs292…

2018
International journal of medical sciences ·doi:10.7150/ijms.26771

Breast cancer is a major cause of cancer mortality amongst women. Chemokine (C-C motif) ligand 4 is encoded by the CCL4 gene; specific CCL4 gene polymorphisms are related to the risks and prognoses of various diseases. In this study, we exa…

2014
PloS one ·doi:10.1371/journal.pone.0115949

BackgroundRadiofrequency ablation (RFA) is one of the curative therapies for hepatocellular carcinoma (HCC), however, accelerated progression of residual HCC after incomplete RFA has been reported more frequently. The underlying molecular m…